
John A. Ward
Examiner (ID: 10393)
| Most Active Art Unit | 2875 |
| Art Unit(s) | 2885, 2875 |
| Total Applications | 1293 |
| Issued Applications | 1015 |
| Pending Applications | 41 |
| Abandoned Applications | 239 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11947494
[patent_doc_number] => 20170251645
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-07
[patent_title] => 'REGULATION OF ENDOGENOUS GENE EXPRESSION IN CELLS USING ZINC FINGER PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 15/499615
[patent_app_country] => US
[patent_app_date] => 2017-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 29845
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15499615
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/499615 | REGULATION OF ENDOGENOUS GENE EXPRESSION IN CELLS USING ZINC FINGER PROTEINS | Apr 26, 2017 | Abandoned |
Array
(
[id] => 12023915
[patent_doc_number] => 20170314013
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-02
[patent_title] => 'SYSTEM FOR PRODUCTION OF ANTIBODIES AND THEIR DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 15/492218
[patent_app_country] => US
[patent_app_date] => 2017-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 26925
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15492218
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/492218 | SYSTEM FOR PRODUCTION OF ANTIBODIES AND THEIR DERIVATIVES | Apr 19, 2017 | Abandoned |
Array
(
[id] => 11992410
[patent_doc_number] => 20170296565
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'MOUSE MODEL AND TREATMENT OF HEREDITARY INCLUSION BODY MYOPATHY'
[patent_app_type] => utility
[patent_app_number] => 15/479761
[patent_app_country] => US
[patent_app_date] => 2017-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7350
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15479761
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/479761 | MOUSE MODEL AND TREATMENT OF HEREDITARY INCLUSION BODY MYOPATHY | Apr 4, 2017 | Abandoned |
Array
(
[id] => 16215377
[patent_doc_number] => 10731177
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-04
[patent_title] => Muscle-specific nucleic acid regulatory elements and methods and use thereof
[patent_app_type] => utility
[patent_app_number] => 15/470367
[patent_app_country] => US
[patent_app_date] => 2017-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 53
[patent_figures_cnt] => 27
[patent_no_of_words] => 30353
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15470367
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/470367 | Muscle-specific nucleic acid regulatory elements and methods and use thereof | Mar 26, 2017 | Issued |
Array
(
[id] => 13297699
[patent_doc_number] => 20180200386
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-19
[patent_title] => COMPOSITIONS AND METHODS TO MODULATE CELL ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 15/464748
[patent_app_country] => US
[patent_app_date] => 2017-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25237
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15464748
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/464748 | Compositions and methods to modulate cell activity | Mar 20, 2017 | Issued |
Array
(
[id] => 12117325
[patent_doc_number] => 20180000912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-04
[patent_title] => 'Virus Vectors Expressing Multiple Epitopes of Tumor Associated Antigens For Inducing Antitumor Immunity'
[patent_app_type] => utility
[patent_app_number] => 15/449641
[patent_app_country] => US
[patent_app_date] => 2017-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 51268
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15449641
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/449641 | Virus Vectors Expressing Multiple Epitopes of Tumor Associated Antigens For Inducing Antitumor Immunity | Mar 2, 2017 | Abandoned |
Array
(
[id] => 11743944
[patent_doc_number] => 20170198017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-13
[patent_title] => 'LIGHT-SENSITIVE ION-PASSING MOLECULES'
[patent_app_type] => utility
[patent_app_number] => 15/447019
[patent_app_country] => US
[patent_app_date] => 2017-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 44794
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15447019
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/447019 | LIGHT-SENSITIVE ION-PASSING MOLECULES | Feb 28, 2017 | Abandoned |
Array
(
[id] => 14069371
[patent_doc_number] => 20190083573
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => DESIGNER RECEPTORS FOR MODULATING PAIN AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/071043
[patent_app_country] => US
[patent_app_date] => 2017-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14897
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16071043
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/071043 | DESIGNER RECEPTORS FOR MODULATING PAIN AND METHODS OF USE THEREOF | Jan 24, 2017 | Abandoned |
Array
(
[id] => 11756091
[patent_doc_number] => 20170202957
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-20
[patent_title] => 'COMPOSITION COMPRISING A COMPLEXED (m)RNA AND A NAKED mRNA FOR PROVIDING OR ENHANCING AN IMMUNOSTIMULATORY RESPONSE IN A MAMMAL AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/408339
[patent_app_country] => US
[patent_app_date] => 2017-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 58070
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15408339
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/408339 | COMPOSITION COMPRISING A COMPLEXED (m)RNA AND A NAKED mRNA FOR PROVIDING OR ENHANCING AN IMMUNOSTIMULATORY RESPONSE IN A MAMMAL AND USES THEREOF | Jan 16, 2017 | Abandoned |
Array
(
[id] => 17998069
[patent_doc_number] => 11499165
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-15
[patent_title] => Targeting peptides for directing adeno-associated viruses (AAVs)
[patent_app_type] => utility
[patent_app_number] => 15/374596
[patent_app_country] => US
[patent_app_date] => 2016-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 89
[patent_no_of_words] => 29099
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15374596
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/374596 | Targeting peptides for directing adeno-associated viruses (AAVs) | Dec 8, 2016 | Issued |
Array
(
[id] => 11668455
[patent_doc_number] => 20170157176
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-08
[patent_title] => 'Smart CAR Devices and DE CAR Polypeptides for Treating Disease and Methods for Enhancing Immune Responses'
[patent_app_type] => utility
[patent_app_number] => 15/369132
[patent_app_country] => US
[patent_app_date] => 2016-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 36216
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15369132
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/369132 | Smart CAR devices and DE CAR polypeptides for treating disease and methods for enhancing immune responses | Dec 4, 2016 | Issued |
Array
(
[id] => 11857396
[patent_doc_number] => 09737059
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-22
[patent_title] => 'Humanized IL-7 rodents'
[patent_app_type] => utility
[patent_app_number] => 15/357021
[patent_app_country] => US
[patent_app_date] => 2016-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8737
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15357021
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/357021 | Humanized IL-7 rodents | Nov 20, 2016 | Issued |
Array
(
[id] => 13425197
[patent_doc_number] => 20180264141
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-20
[patent_title] => A METHOD EFFECTIVE TO MODULATE EXPRESSION OF T-BOX PROTEIN 4 (TBX4) FOR REDUCING PROGRESSION OF LUNG FIBROSIS AFTER A LUNG INJURY
[patent_app_type] => utility
[patent_app_number] => 15/761403
[patent_app_country] => US
[patent_app_date] => 2016-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39478
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15761403
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/761403 | Method effective to modulate expression of T-box protein 4 (Tbx4) for reducing progression of lung fibrosis after a lung injury | Oct 31, 2016 | Issued |
Array
(
[id] => 18085705
[patent_doc_number] => 11535824
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-27
[patent_title] => Nuclear transfer
[patent_app_type] => utility
[patent_app_number] => 15/338144
[patent_app_country] => US
[patent_app_date] => 2016-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13239
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 167
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15338144
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/338144 | Nuclear transfer | Oct 27, 2016 | Issued |
Array
(
[id] => 11436068
[patent_doc_number] => 20170037090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-09
[patent_title] => 'RECOMBINANT EXPRESSION OF MULTIPROTEIN COMPLEXES USING POLYGENES'
[patent_app_type] => utility
[patent_app_number] => 15/334532
[patent_app_country] => US
[patent_app_date] => 2016-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 9007
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15334532
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/334532 | RECOMBINANT EXPRESSION OF MULTIPROTEIN COMPLEXES USING POLYGENES | Oct 25, 2016 | Abandoned |
Array
(
[id] => 17075122
[patent_doc_number] => 11111508
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-07
[patent_title] => Modified CAS9 compositions and methods of use
[patent_app_type] => utility
[patent_app_number] => 15/762025
[patent_app_country] => US
[patent_app_date] => 2016-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 5601
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15762025
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/762025 | Modified CAS9 compositions and methods of use | Oct 24, 2016 | Issued |
Array
(
[id] => 11587697
[patent_doc_number] => 20170112108
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-27
[patent_title] => 'GENETICALLY MODIFIED NON-HUMAN MAMMALS HAVING MODIFIED LIVER CELLS AND/OR TISSUE AND METHODS OF MAKING SAME'
[patent_app_type] => utility
[patent_app_number] => 15/299685
[patent_app_country] => US
[patent_app_date] => 2016-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 5479
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15299685
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/299685 | GENETICALLY MODIFIED NON-HUMAN MAMMALS HAVING MODIFIED LIVER CELLS AND/OR TISSUE AND METHODS OF MAKING SAME | Oct 20, 2016 | Abandoned |
Array
(
[id] => 15005047
[patent_doc_number] => 10448622
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-22
[patent_title] => Human artificial chromosome containing human antibody lambda light chain gene and non-human animal containing the human artificial chromosome capable of genetic transmission
[patent_app_type] => utility
[patent_app_number] => 15/298037
[patent_app_country] => US
[patent_app_date] => 2016-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 14618
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15298037
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/298037 | Human artificial chromosome containing human antibody lambda light chain gene and non-human animal containing the human artificial chromosome capable of genetic transmission | Oct 18, 2016 | Issued |
Array
(
[id] => 12405207
[patent_doc_number] => 09968664
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-15
[patent_title] => Fusion molecule based on novel TAA variant
[patent_app_type] => utility
[patent_app_number] => 15/293710
[patent_app_country] => US
[patent_app_date] => 2016-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 18877
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 187
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15293710
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/293710 | Fusion molecule based on novel TAA variant | Oct 13, 2016 | Issued |
Array
(
[id] => 20115073
[patent_doc_number] => 12364757
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-22
[patent_title] => TCR and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/763419
[patent_app_country] => US
[patent_app_date] => 2016-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 27
[patent_no_of_words] => 13473
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15763419
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/763419 | TCR and uses thereof | Oct 2, 2016 | Issued |